Mucus, microbiomes and lung function decline in COPD
We perform prospective longitudinal microbiome assessment to evaluate individuals with COPD experiencing significant lung function decline, comparing them to individuals with physiological decline. Uncovering change over time provides fresh insight into disease pathogenesis while allowing early identification and improved stratification of COPD at highest risk of experiencing an accelerated lung function decline trajectory.